Header Logo

Connection

MICHELLE A FANALE to Purines

Back to Details
This is a "connection" page, showing publications MICHELLE A FANALE has written about Purines.
MICHELLE A FANALE
Connection Strength
0.128
Purines
  1. Phase II study of idelalisib, a selective inhibitor of PI3Kd, for relapsed/refractory classical Hodgkin lymphoma. Ann Oncol. 2017 May 01; 28(5):1057-1063.
    View in: PubMed
    Score: 0.128
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.